SRPT Today - Aug 13: Demand for Elevidys Slumps

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

SRPT Today - Aug 13: Demand for Elevidys Slumps

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly stock enthusiast. Been investing for years and I’m breaking down the day for you. Today, we’re talking about Sarepta, and it was a bit of a mixed bag, closing the day up about 1.5%.

So, what went down? Well, Sarepta had a pretty decent day overall, but things took a nosedive after hours when news hit that demand for their Elevidys treatment wasn’t looking too hot. People started hitting the sell button pretty quickly. It’s like when you see a bad review for a restaurant and suddenly, you’re not so hungry anymore, you know?

Now, why did this happen? Bank of America decided to boost its investment in Sarepta, which usually sounds like good news, right? But then, right after that, we got the news about Elevidys. The CEO was still feeling optimistic about growth, but the market didn’t seem to buy it. It’s like when your friend keeps saying they’ll get their life together, but you’re still waiting for them to actually do it.

On the bright side, Assenagon Asset Management also made a new investment in Sarepta, dropping over $8 million into the company. That’s some serious cash! But with all the chatter about Elevidys, it kinda felt like a band-aid on a bigger issue.

One thing to keep in mind is that they recently held their Q2 earnings call, so there could be more updates coming soon. Just something to keep in the back of your mind.

So, to wrap it up, Sarepta had a bit of a rollercoaster day. Up a little, but the after-hours dip was definitely a buzzkill. Just remember, this is all for fun and info, not financial advice. Catch you later!

まだレビューはありません